Bill & Melinda Gates FoundationGlobal Grand Challenges
  • Grant Opportunities
  • Challenges
  • Awards
  • Champions
  • Partnerships
  • News
  • About

Tailored Nanodevices to Understand Resistance Against HIV

Juan Cubillos-Ruiz at Weill Cornell Medical College in the U.S. will develop silica nanopore-based assays to capture unique low molecular weight proteins and identify biomarkers associated with host resistance to HIV. Identifying these biomarkers present in the small proportion of HIV-infected individuals who are able to suppress the virus over the long term could lead to new understanding of the processes mediating HIV resistance and to new therapies against the disease.

More information about Explore New Solutions for Global Health Priority Areas (Round 9)